Lemur catta isolate mLemCat1 chromosome 22, mLemCat1.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Strepsirrhini; Lemuriformes; Lemuridae; Lemur.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036493.1.\nAssembly name: mLemCat1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGPY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 16-JUL-2021\nAssembly Method :: hifiasm v. 0.12-r304; purge_dups v.\n 1.2.5; bionano_solve v.\n Solve3.6.1_11162020; salsa2 v. v2.2;\n gEVAL manual curation v. 2021-07-16\nAssembly Name :: mLemCat1.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 20.81x\nSequencing Technology :: Pacbio Sequel II CCS; 10X Genomics linked\n reads; Bionano Genomics DLS; Arima\n Genomics v1 Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Lemur catta Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PR domain zinc finger protein 5-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
uncharacterized LOC123626369, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123626369, transcript variant X4
uncharacterized LOC123626369, transcript variant X1
uncharacterized LOC123626369, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: feline leukemia virus subgroup C receptor-related protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins
uncharacterized LOC123626447, transcript variant X1
uncharacterized LOC123626447, transcript variant X2
putative ankyrin repeat domain-containing protein 20A5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC123626360, transcript variant X2
uncharacterized LOC123626360, transcript variant X1
uncharacterized LOC123626360, transcript variant X3
neuroblastoma breakpoint family member 4-like, transcript variant X5
neuroblastoma breakpoint family member 4-like, transcript variant X1
neuroblastoma breakpoint family member 4-like, transcript variant X3
neuroblastoma breakpoint family member 4-like, transcript variant X2
neuroblastoma breakpoint family member 4-like, transcript variant X11
neuroblastoma breakpoint family member 4-like, transcript variant X8
neuroblastoma breakpoint family member 4-like, transcript variant X10
neuroblastoma breakpoint family member 4-like, transcript variant X7
neuroblastoma breakpoint family member 4-like, transcript variant X9
neuroblastoma breakpoint family member 4-like, transcript variant X6
neuroblastoma breakpoint family member 4-like, transcript variant X4
neuroblastoma breakpoint family member 4-like isoform X2
neuroblastoma breakpoint family member 4-like isoform X1
uncharacterized LOC123626420, transcript variant X3
uncharacterized LOC123626420, transcript variant X2
uncharacterized LOC123626420, transcript variant X1
uncharacterized LOC123626420, transcript variant X4
uncharacterized protein LOC123626420 isoform X3
uncharacterized protein LOC123626420 isoform X2
uncharacterized protein LOC123626420 isoform X1
uncharacterized protein LOC123626420 isoform X4
putative coiled-coil domain-containing protein 144C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative ankyrin repeat domain-containing protein 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123626583, transcript variant X3
uncharacterized LOC123626583, transcript variant X2
uncharacterized LOC123626583, transcript variant X1
uncharacterized LOC123626583, transcript variant X4
ankyrin repeat domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123626586, transcript variant X2
uncharacterized LOC123626586, transcript variant X1
uncharacterized LOC123626586, transcript variant X3
uncharacterized LOC123626586, transcript variant X4
uncharacterized LOC123626588, transcript variant X4
uncharacterized LOC123626588, transcript variant X1
uncharacterized LOC123626588, transcript variant X2
uncharacterized LOC123626588, transcript variant X3
uncharacterized LOC123626587, transcript variant X4
uncharacterized LOC123626587, transcript variant X2
uncharacterized LOC123626587, transcript variant X1
uncharacterized LOC123626587, transcript variant X3
uncharacterized LOC123626587, transcript variant X7
uncharacterized LOC123626587, transcript variant X6
uncharacterized LOC123626587, transcript variant X5
uncharacterized LOC123626587, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X1
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X2
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X3
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X4
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X5
heparan-alpha-glucosaminide N-acetyltransferase isoform X1
heparan-alpha-glucosaminide N-acetyltransferase isoform X2
heparan-alpha-glucosaminide N-acetyltransferase isoform X4
heparan-alpha-glucosaminide N-acetyltransferase isoform X3
heterogeneous nuclear ribonucleoprotein A1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: heterogeneous nuclear ribonucleoprotein A1-like
protein O-mannose kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein O-mannose kinase, transcript variant X5
protein O-mannose kinase, transcript variant X2
protein O-mannose kinase, transcript variant X1
protein O-mannose kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
farnesyltransferase, CAAX box, alpha, transcript variant X2
farnesyltransferase, CAAX box, alpha, transcript variant X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha isoform X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha isoform X1
hook microtubule tethering protein 3, transcript variant X1
hook microtubule tethering protein 3, transcript variant X2
ring finger protein 170, transcript variant X8
ring finger protein 170, transcript variant X9
ring finger protein 170, transcript variant X2
ring finger protein 170, transcript variant X7
ring finger protein 170, transcript variant X3
ring finger protein 170, transcript variant X4
ring finger protein 170, transcript variant X1
ring finger protein 170, transcript variant X5
E3 ubiquitin-protein ligase RNF170 isoform X2
E3 ubiquitin-protein ligase RNF170 isoform X1
ring finger protein 170, transcript variant X6
E3 ubiquitin-protein ligase RNF170 isoform X3
THAP domain containing 1, transcript variant X1
THAP domain containing 1, transcript variant X2
THAP domain-containing protein 1 isoform X1
THAP domain-containing protein 1 isoform X2
solute carrier family 20 member 2, transcript variant X9
solute carrier family 20 member 2, transcript variant X8
solute carrier family 20 member 2, transcript variant X5
solute carrier family 20 member 2, transcript variant X11
solute carrier family 20 member 2, transcript variant X6
solute carrier family 20 member 2, transcript variant X10
solute carrier family 20 member 2, transcript variant X4
solute carrier family 20 member 2, transcript variant X7
solute carrier family 20 member 2, transcript variant X3
solute carrier family 20 member 2, transcript variant X1
solute carrier family 20 member 2, transcript variant X12
solute carrier family 20 member 2, transcript variant X2
solute carrier family 20 member 2, transcript variant X16
solute carrier family 20 member 2, transcript variant X15
sodium-dependent phosphate transporter 2 isoform X1
sodium-dependent phosphate transporter 2 isoform X2
sodium-dependent phosphate transporter 2 isoform X3
solute carrier family 20 member 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 20 member 2, transcript variant X14
small integral membrane protein 19, transcript variant X2
small integral membrane protein 19, transcript variant X1
small integral membrane protein 19, transcript variant X3
small integral membrane protein 19 isoform X1
small integral membrane protein 19 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic beta 3 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit beta-3
cholinergic receptor nicotinic alpha 6 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 15 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit alpha-6
voltage dependent anion channel 3, transcript variant X2
voltage dependent anion channel 3, transcript variant X1
voltage-dependent anion-selective channel protein 3 isoform X2
voltage-dependent anion-selective channel protein 3 isoform X1
dickkopf WNT signaling pathway inhibitor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 4, transcript variant X3
dickkopf WNT signaling pathway inhibitor 4, transcript variant X4
dickkopf WNT signaling pathway inhibitor 4, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X4
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X3
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 136 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 152 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 127 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 154 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X4
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
plasminogen activator, tissue type, transcript variant X1
plasminogen activator, tissue type, transcript variant X2
tissue-type plasminogen activator isoform X1
tissue-type plasminogen activator isoform X2
adaptor related protein complex 3 subunit mu 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
lysine acetyltransferase 6A, transcript variant X1
lysine acetyltransferase 6A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4, transcript variant X1
glycerol-3-phosphate acyltransferase 4, transcript variant X4
glycerol-3-phosphate acyltransferase 4, transcript variant X3
glycerol-3-phosphate acyltransferase 4, transcript variant X6
glycerol-3-phosphate acyltransferase 4 isoform X1
glycerol-3-phosphate acyltransferase 4 isoform X3
glycerol-3-phosphate acyltransferase 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycerol-3-phosphate acyltransferase 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123626621, transcript variant X4
uncharacterized LOC123626621, transcript variant X1
uncharacterized LOC123626621, transcript variant X3
uncharacterized LOC123626621, transcript variant X2
GINS complex subunit 4, transcript variant X2
GINS complex subunit 4, transcript variant X5
GINS complex subunit 4, transcript variant X6
GINS complex subunit 4, transcript variant X1
GINS complex subunit 4, transcript variant X4
GINS complex subunit 4, transcript variant X3
DNA replication complex GINS protein SLD5 isoform X2
DNA replication complex GINS protein SLD5 isoform X1
zinc finger matrin-type 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type 4, transcript variant X2
zinc finger matrin-type 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type 4, transcript variant X1
zinc finger matrin-type protein 4 isoform X2
zinc finger matrin-type protein 4 isoform X3
zinc finger matrin-type protein 4 isoform X1
zinc finger matrin-type 4, transcript variant X5
zinc finger matrin-type 4, transcript variant X6
zinc finger matrin-type 4, transcript variant X7
zinc finger matrin-type protein 4 isoform X4
transcriptional and immune response regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 2
disintegrin and metalloproteinase domain-containing protein 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metallopeptidase domain 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 26% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: squalene monooxygenase-like
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 32-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 32-like isoform X1
disintegrin and metalloproteinase domain-containing protein 32-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 26% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00618
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 32
disintegrin and metalloproteinase domain-containing protein 9
COORDINATES: nucleotide motif:Rfam:12.0:RF00212
pleckstrin homology domain containing A2
pleckstrin homology domain-containing family A member 2
transforming acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil containing protein 1, transcript variant X6
transforming acidic coiled-coil containing protein 1, transcript variant X1
transforming acidic coiled-coil containing protein 1, transcript variant X5
transforming acidic coiled-coil containing protein 1, transcript variant X4
transforming acidic coiled-coil containing protein 1, transcript variant X2
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
fibroblast growth factor receptor 1, transcript variant X4
fibroblast growth factor receptor 1, transcript variant X5
fibroblast growth factor receptor 1, transcript variant X8
fibroblast growth factor receptor 1, transcript variant X9
fibroblast growth factor receptor 1, transcript variant X1
fibroblast growth factor receptor 1, transcript variant X3
fibroblast growth factor receptor 1, transcript variant X6
fibroblast growth factor receptor 1, transcript variant X7
fibroblast growth factor receptor 1, transcript variant X2
fibroblast growth factor receptor 1 isoform X1
fibroblast growth factor receptor 1 isoform X2
fibroblast growth factor receptor 1 isoform X3
fibroblast growth factor receptor 1 isoform X4
fibroblast growth factor receptor 1 isoform X5
fibroblast growth factor receptor 1 isoform X6
fibroblast growth factor receptor 1 isoform X7
fibroblast growth factor receptor 1 isoform X8
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X3
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X2
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LETM1 domain-containing protein LETM2, mitochondrial isoform X3
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
LETM1 domain-containing protein LETM2, mitochondrial isoform X4
nuclear receptor binding SET domain protein 3, transcript variant X1
nuclear receptor binding SET domain protein 3, transcript variant X6
nuclear receptor binding SET domain protein 3, transcript variant X7
nuclear receptor binding SET domain protein 3, transcript variant X8
nuclear receptor binding SET domain protein 3, transcript variant X9
nuclear receptor binding SET domain protein 3, transcript variant X4
nuclear receptor binding SET domain protein 3, transcript variant X2
nuclear receptor binding SET domain protein 3, transcript variant X5
nuclear receptor binding SET domain protein 3, transcript variant X3
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X1
DDHD domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid phosphatase 5, transcript variant X2
phospholipid phosphatase 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid phosphatase 5, transcript variant X1
phospholipid phosphatase 5, transcript variant X3
DDHD domain containing 2, transcript variant X5
phospholipid phosphatase 5, transcript variant X5
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X1
DDHD domain containing 2, transcript variant X3
DDHD domain containing 2, transcript variant X4
DDHD domain containing 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DDHD domain containing 2, transcript variant X7
DDHD domain containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BAG cochaperone 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BAG cochaperone 4, transcript variant X1
BAG family molecular chaperone regulator 4 isoform X1
BAG cochaperone 4, transcript variant X3
BAG cochaperone 4, transcript variant X4
BAG family molecular chaperone regulator 4 isoform X3
BAG family molecular chaperone regulator 4 isoform X4
BAG cochaperone 4, transcript variant X2
BAG family molecular chaperone regulator 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LSM1 homolog, mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm1
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 272 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X4
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X2
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 322 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 308 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X7
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X8
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X2
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X3
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 13 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
steroidogenic acute regulatory protein, mitochondrial
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X6
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X5
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X6
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E binding protein 1
eukaryotic translation initiation factor 4E-binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 29 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
glutamic-oxaloacetic transaminase 1 like 1
putative aspartate aminotransferase, cytoplasmic 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
RAB11 family interacting protein 1, transcript variant X1
RAB11 family interacting protein 1, transcript variant X3
rab11 family-interacting protein 1 isoform X1
rab11 family-interacting protein 1 isoform X3
RAB11 family interacting protein 1, transcript variant X2
rab11 family-interacting protein 1 isoform X2
BRF2 RNA polymerase III transcription initiation factor subunit
transcription factor IIIB 50 kDa subunit
pyridoxal phosphate binding protein, transcript variant X4
pyridoxal phosphate binding protein, transcript variant X3
pyridoxal phosphate binding protein, transcript variant X1
pyridoxal phosphate binding protein, transcript variant X2
pyridoxal phosphate homeostasis protein isoform X2
pyridoxal phosphate homeostasis protein isoform X1
pyridoxal phosphate homeostasis protein isoform X3
ER lipid raft associated 2, transcript variant X2
ER lipid raft associated 2, transcript variant X3
ER lipid raft associated 2, transcript variant X1
potassium calcium-activated channel subfamily U member 1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: potassium channel subfamily U member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
dual specificity phosphatase 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity phosphatase 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 ESTs, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity phosphatase 26, transcript variant X1
dual specificity protein phosphatase 26 isoform X1
dual specificity protein phosphatase 26 isoform X2
dual specificity protein phosphatase 26 isoform X3
ring finger protein 122, transcript variant X1
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X3
TELO2 interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TELO2 interacting protein 2, transcript variant X3
TELO2 interacting protein 2, transcript variant X2
TELO2 interacting protein 2, transcript variant X1
fucosyltransferase 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 37 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fucosyltransferase 10, transcript variant X1
uncharacterized LOC123626482, transcript variant X1
uncharacterized LOC123626482, transcript variant X2
pro-neuregulin-1, membrane-bound isoform isoform X1
pro-neuregulin-1, membrane-bound isoform isoform X2
pro-neuregulin-1, membrane-bound isoform isoform X3
pro-neuregulin-1, membrane-bound isoform isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X5
pro-neuregulin-1, membrane-bound isoform isoform X4
pro-neuregulin-1, membrane-bound isoform isoform X7
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
WRN RecQ like helicase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WRN RecQ like helicase, transcript variant X5
WRN RecQ like helicase, transcript variant X3
WRN RecQ like helicase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WRN RecQ like helicase, transcript variant X2
WRN RecQ like helicase, transcript variant X6
Werner syndrome ATP-dependent helicase isoform X3
Werner syndrome ATP-dependent helicase isoform X4
Werner syndrome ATP-dependent helicase isoform X2
Werner syndrome ATP-dependent helicase isoform X1
Werner syndrome ATP-dependent helicase isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
purine rich element binding protein G, transcript variant X1
purine rich element binding protein G, transcript variant X3
purine rich element binding protein G, transcript variant X2
purine-rich element-binding protein gamma isoform X1
purine-rich element-binding protein gamma isoform X3
purine-rich element-binding protein gamma isoform X2
testis expressed 15, meiosis and synapsis associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 catalytic subunit beta
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
UBX domain protein 8, transcript variant X2
UBX domain protein 8, transcript variant X1
UBX domain-containing protein 8 isoform X2
UBX domain-containing protein 8 isoform X1
glutathione-disulfide reductase, transcript variant X1
glutathione reductase, mitochondrial isoform X1
glutathione-disulfide reductase, transcript variant X2
glutathione reductase, mitochondrial isoform X2
general transcription factor IIE subunit 2
transcription initiation factor IIE subunit beta
RNA binding protein, mRNA processing factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 50 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA-binding protein with multiple splicing isoform X2
RNA binding protein, mRNA processing factor, transcript variant X1
RNA binding protein, mRNA processing factor, transcript variant X2
RNA-binding protein with multiple splicing isoform X1
uncharacterized LOC123626507, transcript variant X1
uncharacterized LOC123626507, transcript variant X2
membrane bound O-acyltransferase domain containing 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
leptin receptor overlapping transcript like 1
leptin receptor overlapping transcript-like 1
store-operated calcium entry associated regulatory factor
store-operated calcium entry-associated regulatory factor
uncharacterized LOC123626409, transcript variant X2
uncharacterized LOC123626409, transcript variant X1
poly [ADP-ribose] polymerase tankyrase-1 isoform X2
poly [ADP-ribose] polymerase tankyrase-1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00571
uncharacterized LOC123626464, transcript variant X2
uncharacterized LOC123626464, transcript variant X1
protein phosphatase 1 regulatory subunit 3B
exoribonuclease 1, transcript variant X1
exoribonuclease 1, transcript variant X3
exoribonuclease 1, transcript variant X2
multifunctional ROCO family signaling regulator 1, transcript variant X2
multifunctional ROCO family signaling regulator 1, transcript variant X1
malignant fibrous histiocytoma-amplified sequence 1
uncharacterized LOC123626468, transcript variant X2
uncharacterized LOC123626468, transcript variant X1
uncharacterized LOC123626468, transcript variant X3
uncharacterized LOC123626468, transcript variant X6
uncharacterized LOC123626468, transcript variant X4
uncharacterized LOC123626468, transcript variant X5
uncharacterized LOC123626468, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X1
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X2
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X3
LON peptidase N-terminal domain and ring finger 1, transcript variant X2
LON peptidase N-terminal domain and ring finger 1, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 1 isoform X2
LON peptidase N-terminal domain and RING finger protein 1 isoform X1
tRNA methyltransferase 9B (putative), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA methyltransferase 9B (putative), transcript variant X2
tRNA methyltransferase 9B (putative), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable tRNA methyltransferase 9B isoform X1
probable tRNA methyltransferase 9B isoform X2
DLC1 Rho GTPase activating protein, transcript variant X1
DLC1 Rho GTPase activating protein, transcript variant X2
DLC1 Rho GTPase activating protein, transcript variant X3
rho GTPase-activating protein 7 isoform X1
rho GTPase-activating protein 7 isoform X2
rho GTPase-activating protein 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 2 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
tumor suppressor candidate 3, transcript variant X2
tumor suppressor candidate 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 227 ESTs, 20 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage scavenger receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage scavenger receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 ESTs, 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage scavenger receptor types I and II isoform X2
macrophage scavenger receptor types I and II isoform X1
macrophage scavenger receptor 1, transcript variant X3
macrophage scavenger receptor types I and II isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 6 ESTs, 11 Proteins
mitochondrial calcium uptake family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 ESTs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial calcium uptake family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial calcium uptake family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial calcium uptake family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium uptake protein 3, mitochondrial isoform X3
calcium uptake protein 3, mitochondrial isoform X1
calcium uptake protein 3, mitochondrial isoform X2
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X2
CCR4-NOT transcription complex subunit 7
VPS37A subunit of ESCRT-I, transcript variant X3
vacuolar protein sorting-associated protein 37A isoform X2
VPS37A subunit of ESCRT-I, transcript variant X1
VPS37A subunit of ESCRT-I, transcript variant X2
vacuolar protein sorting-associated protein 37A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 16 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
platelet derived growth factor receptor like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
platelet-derived growth factor receptor-like protein
microtubule associated scaffold protein 1, transcript variant X2
microtubule associated scaffold protein 1, transcript variant X3
microtubule associated scaffold protein 1, transcript variant X1
microtubule associated scaffold protein 1, transcript variant X4
microtubule associated scaffold protein 1, transcript variant X5
microtubule-associated tumor suppressor 1 isoform X3
microtubule-associated tumor suppressor 1 isoform X2
microtubule-associated tumor suppressor 1 isoform X1
microtubule-associated tumor suppressor 1 isoform X4
microtubule-associated tumor suppressor 1 isoform X5
pericentriolar material 1, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pericentriolar material 1, transcript variant X21
pericentriolar material 1, transcript variant X22
pericentriolar material 1, transcript variant X23
pericentriolar material 1, transcript variant X3
pericentriolar material 1, transcript variant X4
pericentriolar material 1, transcript variant X1
pericentriolar material 1, transcript variant X6
pericentriolar material 1, transcript variant X5
pericentriolar material 1, transcript variant X2
pericentriolar material 1, transcript variant X12
pericentriolar material 1, transcript variant X7
pericentriolar material 1, transcript variant X13
pericentriolar material 1, transcript variant X9
pericentriolar material 1, transcript variant X8
pericentriolar material 1, transcript variant X17
pericentriolar material 1, transcript variant X16
pericentriolar material 1, transcript variant X18
pericentriolar material 1, transcript variant X10
pericentriolar material 1, transcript variant X11
pericentriolar material 1, transcript variant X14
pericentriolar material 1, transcript variant X19
pericentriolar material 1, transcript variant X15
pericentriolar material 1, transcript variant X20
pericentriolar material 1 protein isoform X1
pericentriolar material 1 protein isoform X3
pericentriolar material 1 protein isoform X8
pericentriolar material 1 protein isoform X2
pericentriolar material 1 protein isoform X4
pericentriolar material 1 protein isoform X9
pericentriolar material 1 protein isoform X5
pericentriolar material 1 protein isoform X13
pericentriolar material 1 protein isoform X12
pericentriolar material 1 protein isoform X14
pericentriolar material 1 protein isoform X6
pericentriolar material 1 protein isoform X7
pericentriolar material 1 protein isoform X10
pericentriolar material 1 protein isoform X15
pericentriolar material 1 protein isoform X11
pericentriolar material 1 protein isoform X16
pericentriolar material 1 protein isoform X17
pericentriolar material 1 protein isoform X18
pericentriolar material 1 protein isoform X19
pericentriolar material 1 protein isoform X20
N-acylsphingosine amidohydrolase 1, transcript variant X2
N-acylsphingosine amidohydrolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 719 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
arylamine N-acetyltransferase 1, transcript variant X2
arylamine N-acetyltransferase 1, transcript variant X1
arylamine N-acetyltransferase 1, transcript variant X3
arylamine N-acetyltransferase 1 isoform X1
arylamine N-acetyltransferase 1 isoform X2
arylamine N-acetyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 72 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
arylamine N-acetyltransferase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
arylamine N-acetyltransferase 1-like, transcript variant X3
arylamine N-acetyltransferase 1-like, transcript variant X4
arylamine N-acetyltransferase 1-like, transcript variant X2
pleckstrin and Sec7 domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 62 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X3
pleckstrin and Sec7 domain containing 3, transcript variant X1
PH and SEC7 domain-containing protein 3 isoform X1
pleckstrin and Sec7 domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 14% coverage of the annotated genomic feature by RNAseq alignments
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1
integrator complex subunit 10, transcript variant X1
integrator complex subunit 10, transcript variant X2
integrator complex subunit 10, transcript variant X4
integrator complex subunit 10, transcript variant X5
integrator complex subunit 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
integrator complex subunit 10 isoform X4
integrator complex subunit 10 isoform X1
integrator complex subunit 10 isoform X5
integrator complex subunit 10 isoform X2
integrator complex subunit 10 isoform X3
lipoprotein lipase, transcript variant X1
lipoprotein lipase, transcript variant X2
solute carrier family 18 member A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 18 member A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 18 member A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
chromaffin granule amine transporter isoform X2
chromaffin granule amine transporter isoform X1
chromaffin granule amine transporter isoform X3
V-type proton ATPase subunit B, brain isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper putative tumor suppressor 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
docking protein 2, transcript variant X1
docking protein 2, transcript variant X3
docking protein 2, transcript variant X2
nucleophosmin/nucleoplasmin 2, transcript variant X3
nucleophosmin/nucleoplasmin 2, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X2
nucleophosmin/nucleoplasmin 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X5
dematin actin binding protein, transcript variant X7
dematin actin binding protein, transcript variant X10
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X9
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X8
FHF complex subunit HOOK interacting protein 2B, transcript variant X2
FHF complex subunit HOOK interacting protein 2B, transcript variant X3
FHF complex subunit HOOK interacting protein 2B isoform X2
FHF complex subunit HOOK interacting protein 2B isoform X3
FHF complex subunit HOOK interacting protein 2B, transcript variant X1
FHF complex subunit HOOK interacting protein 2B isoform X1
HR lysine demethylase and nuclear receptor corepressor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
receptor accessory protein 4, transcript variant X2
receptor accessory protein 4, transcript variant X1
receptor expression-enhancing protein 4 isoform X2
receptor expression-enhancing protein 4 isoform X1
uncharacterized LOC123626473, transcript variant X1
uncharacterized LOC123626473, transcript variant X3
uncharacterized LOC123626473, transcript variant X2
uncharacterized LOC123626473, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 12 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
pulmonary surfactant-associated protein C
bone morphogenetic protein 1, transcript variant X1
bone morphogenetic protein 1, transcript variant X4
bone morphogenetic protein 1, transcript variant X2
bone morphogenetic protein 1, transcript variant X3
phytanoyl-CoA 2-hydroxylase interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 38 ESTs, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phytanoyl-CoA hydroxylase-interacting protein
RNA polymerase III subunit D, transcript variant X1
RNA polymerase III subunit D, transcript variant X2
DNA-directed RNA polymerase III subunit RPC4
piwi like RNA-mediated gene silencing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 17 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
piwi like RNA-mediated gene silencing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 39 member 14, transcript variant X2
solute carrier family 39 member 14, transcript variant X1
solute carrier family 39 member 14, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X1
protein phosphatase 3 catalytic subunit gamma, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X2
protein phosphatase 3 catalytic subunit gamma, transcript variant X5
protein phosphatase 3 catalytic subunit gamma, transcript variant X4
protein phosphatase 3 catalytic subunit gamma, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PDZ and LIM domain protein 2
chromosome 22 C8orf58 homolog, transcript variant X1
chromosome 22 C8orf58 homolog, transcript variant X2
uncharacterized protein C8orf58 homolog isoform X1
uncharacterized protein C8orf58 homolog isoform X2
cell cycle and apoptosis regulator 2, transcript variant X2
cell cycle and apoptosis regulator 2, transcript variant X1
cell cycle and apoptosis regulator 2, transcript variant X3
cell cycle and apoptosis regulator protein 2 isoform X1
cell cycle and apoptosis regulator protein 2 isoform X2
cell cycle and apoptosis regulator protein 2 isoform X3
bridging integrator 3, transcript variant X1
bridging integrator 3, transcript variant X2
early growth response 3, transcript variant X1
early growth response 3, transcript variant X2
early growth response protein 3 isoform X1
early growth response protein 3 isoform X2
phosphatidylethanolamine binding protein 4, transcript variant X3
phosphatidylethanolamine binding protein 4, transcript variant X4
phosphatidylethanolamine binding protein 4, transcript variant X1
phosphatidylethanolamine binding protein 4, transcript variant X2
phosphatidylethanolamine-binding protein 4
Rho related BTB domain containing 2, transcript variant X1
rho-related BTB domain-containing protein 2 isoform X1
Rho related BTB domain containing 2, transcript variant X2
rho-related BTB domain-containing protein 2 isoform X2
tumor necrosis factor receptor superfamily member 10B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 10B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 10B-like isoform X2
tumor necrosis factor receptor superfamily member 10B-like isoform X1
charged multivesicular body protein 7, transcript variant X1
charged multivesicular body protein 7, transcript variant X2
charged multivesicular body protein 7 isoform X1
charged multivesicular body protein 7 isoform X2
R3H and coiled-coil domain-containing protein 1
lysyl oxidase like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 230 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysyl oxidase like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 158 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
solute carrier family 25 member 37, transcript variant X1
solute carrier family 25 member 37, transcript variant X4
solute carrier family 25 member 37, transcript variant X5
solute carrier family 25 member 37, transcript variant X8
solute carrier family 25 member 37, transcript variant X2
solute carrier family 25 member 37, transcript variant X3
solute carrier family 25 member 37, transcript variant X6
solute carrier family 25 member 37, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase domain 28, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase domain 28, transcript variant X1
ADAM metallopeptidase domain 28, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 28 isoform X3
disintegrin and metalloproteinase domain-containing protein 28 isoform X4
disintegrin and metalloproteinase domain-containing protein 28 isoform X1
ADAM metallopeptidase domain 28, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 28 isoform X2
ADAM like decysin 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 245 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM like decysin 1, transcript variant X1
ADAM metallopeptidase domain 7, transcript variant X1
ADAM metallopeptidase domain 7, transcript variant X2
ADAM metallopeptidase domain 7, transcript variant X3
disintegrin and metalloproteinase domain-containing protein 7 isoform X3
disintegrin and metalloproteinase domain-containing protein 7 isoform X1
disintegrin and metalloproteinase domain-containing protein 7 isoform X2
ADAM metallopeptidase domain 7, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 7 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00284
neurofilament medium chain, transcript variant X2
neurofilament medium chain, transcript variant X1
neurofilament medium polypeptide isoform X1
neurofilament medium polypeptide isoform X2
uncharacterized LOC123626636, transcript variant X1
uncharacterized LOC123626636, transcript variant X2
gonadotropin releasing hormone 1, transcript variant X2
gonadotropin releasing hormone 1, transcript variant X1
potassium channel tetramerization domain containing 9, transcript variant X1
potassium channel tetramerization domain containing 9, transcript variant X2
BTB/POZ domain-containing protein KCTD9 isoform X1
BTB/POZ domain-containing protein KCTD9 isoform X2
cell division cycle associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle associated 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 9 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle-associated protein 2 isoform X1
cell division cycle-associated protein 2 isoform X3
cell division cycle associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle-associated protein 2 isoform X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X1
protein phosphatase 2 regulatory subunit Balpha, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X5
protein phosphatase 2 regulatory subunit Balpha, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
protein phosphatase 2 regulatory subunit Balpha, transcript variant X6
protein phosphatase 2 regulatory subunit Balpha, transcript variant X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X4
BCL2 interacting protein 3 like, transcript variant X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X1
BCL2 interacting protein 3 like, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00591
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins
adrenoceptor alpha 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 ESTs, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 6 ESTs, 41 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123626644, transcript variant X2
uncharacterized LOC123626644, transcript variant X1
uncharacterized LOC123626645, transcript variant X1
uncharacterized LOC123626645, transcript variant X4
uncharacterized LOC123626645, transcript variant X3
uncharacterized LOC123626645, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine kinase 2 beta, transcript variant X1
protein tyrosine kinase 2 beta, transcript variant X2
protein-tyrosine kinase 2-beta isoform X1
protein-tyrosine kinase 2-beta isoform X2
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X4
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X2
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X1
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X3
neuronal acetylcholine receptor subunit alpha-2 isoform X4
neuronal acetylcholine receptor subunit alpha-2 isoform X2
neuronal acetylcholine receptor subunit alpha-2 isoform X1
neuronal acetylcholine receptor subunit alpha-2 isoform X3
epoxide hydrolase 2, transcript variant X2
epoxide hydrolase 2, transcript variant X1
bifunctional epoxide hydrolase 2 isoform X2
bifunctional epoxide hydrolase 2 isoform X1
scavenger receptor class A member 3, transcript variant X2
scavenger receptor class A member 3 isoform X2
scavenger receptor class A member 3, transcript variant X3
scavenger receptor class A member 3, transcript variant X1
scavenger receptor class A member 3 isoform X1
scavenger receptor class A member 3 isoform X3
coiled-coil domain-containing protein 25
establishment of sister chromatid cohesion N-acetyltransferase 2, transcript variant X1
establishment of sister chromatid cohesion N-acetyltransferase 2, transcript variant X2
lymphokine-activated killer T-cell-originated protein kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
nuclear GTPase, germinal center associated, transcript variant X2
nuclear GTPase, germinal center associated, transcript variant X3
nuclear GTPase, germinal center associated, transcript variant X1
nuclear GTPase, germinal center associated, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear GTPase, germinal center associated, transcript variant X4
elongator acetyltransferase complex subunit 3, transcript variant X1
elongator acetyltransferase complex subunit 3, transcript variant X2
elongator acetyltransferase complex subunit 3, transcript variant X3
zinc finger protein 395, transcript variant X7
zinc finger protein 395, transcript variant X4
zinc finger protein 395, transcript variant X6
zinc finger protein 395, transcript variant X5
zinc finger protein 395, transcript variant X3
zinc finger protein 395, transcript variant X1
zinc finger protein 395, transcript variant X2
uncharacterized LOC123626526, transcript variant X2
uncharacterized LOC123626526, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
frizzled class receptor 3, transcript variant X2
frizzled class receptor 3, transcript variant X1
frizzled class receptor 3, transcript variant X4
frizzled class receptor 3, transcript variant X3
frizzled class receptor 3, transcript variant X5
exostosin like glycosyltransferase 3, transcript variant X5
exostosin like glycosyltransferase 3, transcript variant X1
exostosin like glycosyltransferase 3, transcript variant X2
exostosin like glycosyltransferase 3, transcript variant X4
exostosin like glycosyltransferase 3, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 ESTs, 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: integrator complex subunit 9
homeobox containing 1, transcript variant X1
homeobox containing 1, transcript variant X3
homeobox containing 1, transcript variant X2
homeobox containing 1, transcript variant X6
homeobox containing 1, transcript variant X4
homeobox containing 1, transcript variant X7
homeobox containing 1, transcript variant X5
homeobox containing 1, transcript variant X8
homeobox containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 56 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
homeobox-containing protein 1 isoform X1
homeobox-containing protein 1 isoform X4
homeobox-containing protein 1 isoform X2
homeobox-containing protein 1 isoform X5
homeobox-containing protein 1 isoform X3
homeobox-containing protein 1 isoform X6
homeobox-containing protein 1 isoform X7
kinesin family member 13B, transcript variant X2
kinesin family member 13B, transcript variant X1
methionine sulfoxide reductase A, transcript variant X1
methionine sulfoxide reductase A, transcript variant X2
mitochondrial peptide methionine sulfoxide reductase isoform X1
mitochondrial peptide methionine sulfoxide reductase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
PIN2 (TERF1) interacting telomerase inhibitor 1
PIN2/TERF1-interacting telomerase inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 4 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
L-threonine 3-dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 167 member A, transcript variant X2
family with sequence similarity 167 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BLK proto-oncogene, Src family tyrosine kinase
nei like DNA glycosylase 2, transcript variant X1
nei like DNA glycosylase 2, transcript variant X2
nei like DNA glycosylase 2, transcript variant X3
farnesyl-diphosphate farnesyltransferase 1, transcript variant X2
farnesyl-diphosphate farnesyltransferase 1, transcript variant X1
putative protein FAM90A13P, transcript variant X2
putative protein FAM90A13P, transcript variant X1
putative protein FAM90A13P, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 17-like protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins
defensin beta 105B, transcript variant X2
defensin beta 105B, transcript variant X3
defensin beta 105B, transcript variant X1
defensin beta 105B, transcript variant X4
defensin beta 105B, transcript variant X5
defensin beta 105B, transcript variant X6
defensin beta 105B, transcript variant X8
defensin beta 105B, transcript variant X7
defensin beta 105B, transcript variant X9
uncharacterized LOC123626560, transcript variant X4
uncharacterized LOC123626560, transcript variant X3
uncharacterized LOC123626560, transcript variant X6
uncharacterized LOC123626560, transcript variant X2
uncharacterized LOC123626560, transcript variant X1
uncharacterized LOC123626560, transcript variant X5
neutrophil defensin 4-like, transcript variant X1
neutrophil defensin 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
1-acylglycerol-3-phosphate O-acyltransferase 5
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon
uncharacterized LOC123626573, transcript variant X2
uncharacterized LOC123626573, transcript variant X3
uncharacterized LOC123626573, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 61 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 7 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
CUB and sushi domain-containing protein 1
kelch repeat and BTB domain containing 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain-containing protein 11
Rho guanine nucleotide exchange factor 10
CLN8 transmembrane ER and ERGIC protein, transcript variant X5
CLN8 transmembrane ER and ERGIC protein, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X3
CLN8 transmembrane ER and ERGIC protein, transcript variant X6
CLN8 transmembrane ER and ERGIC protein, transcript variant X1
CLN8 transmembrane ER and ERGIC protein, transcript variant X4
DLG associated protein 2, transcript variant X2
DLG associated protein 2, transcript variant X1
uncharacterized LOC123626703, transcript variant X1
uncharacterized LOC123626703, transcript variant X2
uncharacterized LOC123626702, transcript variant X1
uncharacterized LOC123626702, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 43 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 81 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 81 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 596, transcript variant X3
zinc finger protein 596, transcript variant X2
zinc finger protein 596, transcript variant X4
zinc finger protein 596, transcript variant X5
zinc finger protein 596, transcript variant X6
zinc finger protein 596, transcript variant X1
zinc finger protein 596, transcript variant X7
uncharacterized LOC123626699, transcript variant X2
uncharacterized LOC123626699, transcript variant X1
laminin subunit alpha-5-like, transcript variant X2
laminin subunit alpha-5-like, transcript variant X1
uncharacterized protein LOC123626387 isoform X1